Search clinical trials for: 1.25mg bevacizumab

Total 3036 results

University of New Mexico

Completed

Ferumoxytol-enhanced Imaging of Osteomyelitis

Osteomyelitis

United States
University Medical Center Groningen
Dutch Cancer Society

Completed

Visualization of Rectal Cancer During Endoscopy, Using a Fluorescent Tracer (RAPIDO-TRACT)

Rectal Cancer

Netherlands
Case Comprehensive Cancer Center

Active, not recruiting

Nivolumab Plus Standard Dose Bevacizumab Versus Nivolumab Plus Low Dose Bevacizumab in GBM

Glioblastoma

United States
Chong Kun Dang Pharmaceutical

Completed

CKD-396 Drug-drug Interaction Study(A) (CKD-396 DDI(A) P1)

Diabetes Mellitus, Type II

Korea, Republic of
University of Chicago

Active, not recruiting

Low-dose Tocilizumab Versus Standard of Care in Hospitalized Patients With COVID-19 (COVIDOSE-2)

COVID-19

United States
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian Cancer

Recurrent Ovarian Cancer

China
Chongqing University Cancer Hospital

Recruiting

Fluzoparib Combined With Bevacizumab in PSROC Previously Treated With PARPi

Ovarian Cancer

China
Hospices Civils de Lyon

Active, not recruiting

Assessment of the Efficacy of Bevacizumab in Combination With Folfiri as Second-line Treatment in Patients Suffering From an Advanced Inoperable Poorly Differentiated Neuroendocrine Carcinoma of an Unknown or Gastroentero-pancreatic Primary Cancer (BEVANEC)

Neuroendocrine Carcinomas

France
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI); Genentech, Inc.

Completed

Chemoembolization and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed With Surgery

Liver Cancer

United States
Assistance Publique - Hôpitaux de Paris

Unknown

Trial Evaluating Efficacy and Safety of Bevacizumab (Avastin®/Zeribev®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort (CORIMMUNO-BEVA)

COVID19 Pneumonia
University of California, San Diego

Completed

Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)

Hereditary Hemorrhagic Telangiectasia (HHT)

United States
Boehringer Ingelheim

Completed

Pharmacokinetics and Safety Study of BI 695502 in Healthy Subjects

Healthy

New Zealand
Genentech, Inc.

Withdrawn

Efficacy and Safety Study of rhuMAb VEGF to Treat Metastatic Renal Cell Carcinoma

Renal Cell Cancer
Neon Hospital
Ondokuz Mayıs University

Completed

The Efficacy of Subconjunctival Bevacizumab in Diabetic Macular Edema

Diabetic Macular Edema
ARCAGY/ GINECO GROUP

Completed

First Line Metastatic Breast Cancer Treatment (ESMERALDA) (ESMERALDA)

Metastatic Breast Cancer

France
Children's Hospital Los Angeles

Temporarily not available

Use of Pan-Vascular Endothelial Growth Factor Receptor (Pan-VEGF) Blockade for the Treatment of Retinopathy of Prematurity (ROP) (Compassionate Use BLOCK-ROP)

Retinopathy of Prematurity

United States
Asociación para Evitar la Ceguera en México

Terminated

Intravitreal Bevacizumab for Diabetic Retinopathy

Proliferative Diabetic Retinopathy | Severe Nonproliferative | Active Photocoagulated Diabetic Retinopathy

Mexico
West Penn Allegheny Health System

Withdrawn

Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab

Glioblastoma | Optic Neuropathy
University Medical Center Groningen

Completed

FLuoresence Image Guided Surgery With A VEGF-targeted Tracer in Soft-tissue Sarcomas in Humans Approach With Bevacizumab-IRDye 800CW (FLASH)

Soft Tissue Sarcoma

Netherlands
Sun Yat-sen University

Unknown

Sintilimab Combined With Bevacizumab for Brain Metastases From Non-small Cell Lung Cancer

Non Small Cell Lung Cancer | Bevacizumab | Brain Metastases | Sintilimab

China
Changhua Christian Hospital

Completed

Long-term Outcome of Punctate Inner Choroidopathy or Multifocal Choroiditis With Active Choroidal Neovascularization Managed With Anti-vascular Endothelial Growth Factor

Choroidal Neovascularization | Punctate Inner Choroidopathy

Taiwan
Beijing Hospital

Unknown

Effectiveness and Safety of Adding Bevacizumab to First Line Chemotherapy in Lung Cancer Patients With Stable Disease

Non-small Cell Lung Cancer Metastatic
Jiangsu Aosaikang Pharmaceutical Co., Ltd.

Unknown

Pharmacokinetics and Safety Study of ASKB1202 in Chinese Healthy Subjects

Healthy
University of Zurich

Completed

Impact of Pre-operative Bevacizumab on Complications After Resection of Colorectal Liver Metastases

Colorectal Liver Metastases

Switzerland, France, Spain
Paul Monk
Genentech, Inc.

Terminated

Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer

Kidney Cancer

United States
Genentech, Inc.

Completed

A Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study

Breast Cancer | Colorectal Cancer | Metastases
Genentech, Inc.

Completed

A Study to Evaluate Avastin in Combination With Standard Chemotherapy to Treat Colorectal Cancer

Colorectal Cancer
Peking University

Unknown

Phase I Trial of Intraperitoneal Bevacizumab in Refractory Malignant Ascites

Refractory Malignant Ascites

China
LiNanlin,Ph.D, Chief Physician,Clinical Professor
Roche Pharma AG

Unknown

Observational Studies of the Application of Bevacizumab in HER2-negative Breast Cancer Neoadjuvant Chemotherapy (BIBC)

Breast Cancer | Bevacizumab | Neoadjuvant Chemotherapy | Molecular Targeted Therapy

China
Shahid Beheshti University of Medical Sciences

Completed

Intravitreal Bevasizumab VS Sham Treatment in Acute BRVO: A Randomized Clinical Trial

Retinal Disease

Iran, Islamic Republic of
Asociación para Evitar la Ceguera en México

Unknown

Use of Intravitreal Bevacizumab in Eyes With Choroidal Neovascularization Secondary to Angioid Streaks

Choroidal Neovascularization | Angioid Streaks

Mexico
Grewal Eye Institute

Unknown

Subconjunctival Bevacizumab to Prevent Bleb Failure After Glaucoma Filtration Surgery

Glaucoma

India
Asan Medical Center

Unknown

Intravitreal Bevacizumab for Polypoidal Choroidal Vasculopathy

Polypoidal Choroidal Vasculopathy

Korea, Republic of
Dutch Colorectal Cancer Group
Sanofi; Roche Pharma AG; Koningin Wilhelmina Fonds; Immunicon

Completed

Cetuximab, Capecitabine, Oxaliplatin and Bevacizumab in Advanced Colorectal Cancer

Colorectal Cancer

Netherlands
Taipei Medical University Hospital

Completed

Salvage Therapy With Bevacizumab Plus Docetaxel and Cisplatin for Taiwanese Metastatic Breast Cancer

Metastatic Breast Cancer

Taiwan
Centus Biotherapeutics Limited

Completed

Evaluation of FKB238 and Avastin in Patients With Advanced/Recurrent Non-squamous Non-small Cell Lung Cancer (AVANA)

Carcinoma, Non-Small-Cell Lung

United States, Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, Georgia, Germany, Greece, Hungary, Italy, Japan, Korea, Republic of, Peru, Philippines, Poland, Romania, Russian Federation, Serbia, Spain, Taiwan, Thailand, Turkey, Ukrain... and more
Pfizer

Completed

A Comparative Study Of PF-06439535 Plus Paclitaxel-Carboplatin And Bevacizumab Plus Paclitaxel-Carboplatin Patients With Advanced Non-Squamous NSCLC

Non-Small Cell Lung Cancer

Germany, Spain, Greece, Korea, Republic of, India, United States, Netherlands, Taiwan, Japan, Hungary, Russian Federation, Philippines, Poland, Australia, Brazil, Croatia, South Africa, Turkey, Romania, Chile, Ukraine, Bulgaria, Cze... and more
National Cancer Institute (NCI)
NRG Oncology

Recruiting

Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer, the COMMIT Study

Metastatic Colorectal Adenocarcinoma | Stage IV Colorectal Cancer AJCC v7

United States
InQpharm Group

Completed

Benefit and Tolerability of IQP-AE-103 in Weight Loss

Obesity | Overweight

Germany
Zhejiang Teruisi Pharmaceutical Inc.

Not yet recruiting

A Study Assessing the Interchangeability Between TRS003 and Bevacizumab® For CRC (CRC)

Metastatic Colorectal Cancer (CRC)
CHA University

Recruiting

Predictive Biomarkers in Patients With Advanced Hepatocellular Carcinoma Treated With Systemic Therapy (HCC)

Hepatocellular Carcinoma

Korea, Republic of
Hoffmann-La Roche

Completed

A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer.

Non-Squamous Non-Small Cell Lung Cancer

Australia, France, Germany, Spain, China, Hong Kong, Canada, Sweden, Colombia, Taiwan, United Kingdom, Russian Federation, Finland, Austria, Estonia, Hungary, Netherlands, Latvia, Italy, Mexico, Slovenia, Turkey, Bosnia and Herzegovina and more
National Cancer Institute (NCI)

Recruiting

Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers

Recurrent Head and Neck Squamous Cell Carcinoma | Recurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous Cell Carcinoma | Metastatic Head and Neck Squamous Cell Carcinoma | Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Stage IV Hypopharyngeal... and other conditions

United States
Tianjin Medical University Cancer Institute and...

Not yet recruiting

HAIC Combined With Cadonilimab and Bevacizumab as First-line Therapy in Unresectable Hepatocellular Carcinoma

Unrescetable Hepatocellular Carcinoma

China
Fudan University

Not yet recruiting

The Efficacy and Safety of The Fuzuloparib Combination With Bevacizumab

Recurrent Ovarian Cancer

China
Sun Yat-sen University

Recruiting

TACE Combined With Sintilimab Plus Bevacizumab Biosimilar in Hepatocellular Carcinoma (BCLC-C Stage ): a Prospective Single-arm Phase II Clinical Study (T-Double)

Hepatocellular Carcinoma

China
Asociación para Evitar la Ceguera en México

Withdrawn

Intravitreal Bevacizumab for Inflammatory Neovascular Membranes

Vogt Koyanagi Harada Disease | Multifocal Choroiditis | Serpiginous Choroiditis

Mexico
SCRI Development Innovations, LLC
Novartis

Completed

INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme

Renal Cell Carcinoma | Colorectal Cancer | Glioblastoma Multiforme | Gliosarcoma

United States
University Medical Center Groningen
Helmholtz Zentrum München

Unknown

Detection of Early Esophageal Cancer by NIR-FME. (ESCEND)

Barrett Esophagus

Netherlands
Abramson Cancer Center of the University of Pennsylvania

Withdrawn

DCE-MRI PET Bevacizumab Study in Rectal Cancer

Rectal Cancer Patients

Search clinical trials for: 1.25mg bevacizumab

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Costa Rica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations